An Investigational Study of ESK-001 in Participants With Normal Renal Function and Participants With Mild, Moderate, and Severe Impaired Renal Function

Completed · Phase 1

Conditions studied: Renal Impairment

In brief

This a phase 1, open label, single dose, parallel cohort study to determine the pharmacokinetics (PK) of study drug (ESK-001) in healthy volunteer participants, and participants with mild, moderate, and severe renal impairment.

Key facts

Study ID

NCT06962774

Run by

Alumis Inc

People needed

16

Starts

2025-04-23

Expected to finish

2025-08-01

Last updated by the study team

2025-12-10

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

Where it is running

• Advanced Pharma CR — Miami, Florida, United States
• Panax Clinical Research — Miami Lakes, Florida, United States
• Floridian Clinical Research — Miami Lakes, Florida, United States
• Orlando Clinical Research Center — Orlando, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.